OBJECTIVES: We examined relationships of spatial access to syringe exchange programs (SEPs) and pharmacies selling over-the-counter (OTC) syringes with New York City drug injectors' harm reduction practices. METHODS: Each year from 1995 to 2006, we measured the percentage of 42 city health districts' surface area that was within 1 mile of an SEP or OTC pharmacy. We applied hierarchical generalized linear models to investigate relationships between these exposures and the odds that injectors (n = 4003) used a sterile syringe for at least 75% of injections in the past 6 months. RESULTS: A 1-unit increase in the natural log of the percentage of a district's surface area within a mile of an SEP in 1995 was associated with a 26% increase in the odds of injecting with a sterile syringe; a 1-unit increase in this exposure over time increased these odds 23%. A 1-unit increase in the natural log of OTC pharmacy access improved these odds 15%. CONCLUSIONS: Greater spatial access to SEPs and OTC pharmacies improved injectors' capacity to engage in harm reduction practices that reduce HIV and HCV transmission.
OBJECTIVES: We examined relationships of spatial access to syringe exchange programs (SEPs) and pharmacies selling over-the-counter (OTC) syringes with New York City drug injectors' harm reduction practices. METHODS: Each year from 1995 to 2006, we measured the percentage of 42 city health districts' surface area that was within 1 mile of an SEP or OTC pharmacy. We applied hierarchical generalized linear models to investigate relationships between these exposures and the odds that injectors (n = 4003) used a sterile syringe for at least 75% of injections in the past 6 months. RESULTS: A 1-unit increase in the natural log of the percentage of a district's surface area within a mile of an SEP in 1995 was associated with a 26% increase in the odds of injecting with a sterile syringe; a 1-unit increase in this exposure over time increased these odds 23%. A 1-unit increase in the natural log of OTC pharmacy access improved these odds 15%. CONCLUSIONS: Greater spatial access to SEPs and OTC pharmacies improved injectors' capacity to engage in harm reduction practices that reduce HIV and HCV transmission.
Authors: C Des Jarlais; T Perlis; S R Friedman; T Chapman; J Kwok; R Rockwell; D Paone; J Milliken; E Monterroso Journal: Am J Public Health Date: 2000-07 Impact factor: 9.308
Authors: Benny J Kottiri; Samuel R Friedman; Alan Neaigus; Richard Curtis; Don C Des Jarlais Journal: J Acquir Immune Defic Syndr Date: 2002-05-01 Impact factor: 3.731
Authors: David R Gibson; Richard Brand; Kim Anderson; James G Kahn; Daniel Perales; Joseph Guydish Journal: J Acquir Immune Defic Syndr Date: 2002-10-01 Impact factor: 3.731
Authors: Susanne B Montgomery; Justeen Hyde; Christine Johnson De Rosa; Louise Ann Rohrbach; Susan Ennett; S Marie Harvey; Michael Clatts; Ellen Iverson; Michele D Kipke Journal: Am J Drug Alcohol Abuse Date: 2002 Impact factor: 3.829
Authors: Hannah L F Cooper; Brooke West; Sabriya Linton; Josalin Hunter-Jones; Maria Zlotorzynska; Ron Stall; Mary E Wolfe; Leslie Williams; H Irene Hall; Charles Cleland; Barbara Tempalski; Samuel R Friedman Journal: Am J Public Health Date: 2015-12-21 Impact factor: 9.308
Authors: Hannah Cooper; Don Des Jarlais; Zev Ross; Barbara Tempalski; Brian H Bossak; Samuel R Friedman Journal: J Urban Health Date: 2012-08 Impact factor: 3.671
Authors: Natalie D Crawford; Silvia Amesty; Alexis V Rivera; Katherine Harripersaud; Alezandria Turner; Crystal M Fuller Journal: Am J Public Health Date: 2013-07-18 Impact factor: 9.308
Authors: J F G Monteiro; D J Escudero; C Weinreb; T Flanigan; S Galea; S R Friedman; B D L Marshall Journal: Epidemiol Infect Date: 2016-01-12 Impact factor: 2.451
Authors: Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady Journal: Public Health Rep Date: 2020 Jul/Aug Impact factor: 2.792
Authors: Sabriya L Linton; Hannah L F Cooper; Mary E Kelley; Conny C Karnes; Zev Ross; Mary E Wolfe; Yen-Tyng Chen; Samuel R Friedman; Don Des Jarlais; Salaam Semaan; Barbara Tempalski; Catlainn Sionean; Elizabeth DiNenno; Cyprian Wejnert; Gabriela Paz-Bailey Journal: Ann Epidemiol Date: 2016-08-08 Impact factor: 3.797
Authors: Samuel R Friedman; Barbara Tempalski; Joanne E Brady; Brooke S West; Enrique R Pouget; Leslie D Williams; Don C Des Jarlais; Hannah L F Cooper Journal: Int J Drug Policy Date: 2016-03-11